CREB activation mediates VEGF-A's protection of neurons and cerebral vascular endothelial cells

Hsueh Te Lee, Ying Chao Chang, Yi Fang Tu, Chao Ching Huang

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Hypoxic ischemia (HI) in neonates causes significant neurodevelopmental sequelae. Pharmacological agents designed to target specific transcription factors expressed in neurons and vasculature may provide powerful therapy against HI. Vascular endothelial growth factor-A (VEGF-A) and cAMP response element-binding protein (CREB) both underlie learning and memory, and survival of the nervous system. We examined whether CREB activation is a shared pathway underlying VEGF-A's protection in neurons and cerebral vascular endothelial cells. VEGF-A was used in a HI model of rat pups and in oxygen-glucose- deprivation (OGD) models of immortalized H19-7 neurons and b.End3 cerebral vascular endothelial cells. We found that VEGF-A activated VEGF receptor-2 (VEGFR-2), phosphorylated CREB in neurons and endothelial cells, and protected against HI, and inhibiting VEGFR-2 before VEGF-A reduced the protective effect of VEGF-A in rat pups. VEGF-A also up-regulated VEGFR-2 and phosphorylated CREB, and protected H19-7 neurons and b.End3 endothelial cells against OGD. Inhibiting VEGFR-2 and extracellular signal-regulated kinase (ERK), respectively, reduced VEGF-A-induced CREB phosphorylation and protection of H19-7 and b.End3 cells against OGD. Transfecting H19-7 and b.End3 cells with a serine-133 phosphorylation mutant CREB also inhibited VEGF-A's protection of both types of cells. We conclude that CREB phosphorylation through VEGFR-2/ERK signaling is the shared pathway that underlies VEGF-A's protection of neurons and vascular endothelial cells.

Original languageEnglish
Pages (from-to)79-91
Number of pages13
JournalJournal of Neurochemistry
Volume113
Issue number1
DOIs
Publication statusPublished - Apr 2010
Externally publishedYes

Fingerprint

Cyclic AMP Response Element-Binding Protein
Endothelial cells
Vascular Endothelial Growth Factor A
Neurons
Endothelial Cells
Chemical activation
Vascular Endothelial Growth Factor Receptor
Phosphorylation
Ischemia
Mitogen-Activated Protein Kinase 1
Oxygen
Glucose
Rats
Neuroprotection
Cytoprotection
Neurology
Mutant Proteins
Serine
Nervous System
Transcription Factors

Keywords

  • cAMP response element-binding protein
  • Endothelial cell
  • Hypoxia
  • Neuron
  • Vascular endothelial growth factor receptor-2
  • Vascular endothelial growth factor-A

ASJC Scopus subject areas

  • Biochemistry
  • Cellular and Molecular Neuroscience

Cite this

CREB activation mediates VEGF-A's protection of neurons and cerebral vascular endothelial cells. / Lee, Hsueh Te; Chang, Ying Chao; Tu, Yi Fang; Huang, Chao Ching.

In: Journal of Neurochemistry, Vol. 113, No. 1, 04.2010, p. 79-91.

Research output: Contribution to journalArticle

@article{56f43d4f4f254f778da84422f0b0d841,
title = "CREB activation mediates VEGF-A's protection of neurons and cerebral vascular endothelial cells",
abstract = "Hypoxic ischemia (HI) in neonates causes significant neurodevelopmental sequelae. Pharmacological agents designed to target specific transcription factors expressed in neurons and vasculature may provide powerful therapy against HI. Vascular endothelial growth factor-A (VEGF-A) and cAMP response element-binding protein (CREB) both underlie learning and memory, and survival of the nervous system. We examined whether CREB activation is a shared pathway underlying VEGF-A's protection in neurons and cerebral vascular endothelial cells. VEGF-A was used in a HI model of rat pups and in oxygen-glucose- deprivation (OGD) models of immortalized H19-7 neurons and b.End3 cerebral vascular endothelial cells. We found that VEGF-A activated VEGF receptor-2 (VEGFR-2), phosphorylated CREB in neurons and endothelial cells, and protected against HI, and inhibiting VEGFR-2 before VEGF-A reduced the protective effect of VEGF-A in rat pups. VEGF-A also up-regulated VEGFR-2 and phosphorylated CREB, and protected H19-7 neurons and b.End3 endothelial cells against OGD. Inhibiting VEGFR-2 and extracellular signal-regulated kinase (ERK), respectively, reduced VEGF-A-induced CREB phosphorylation and protection of H19-7 and b.End3 cells against OGD. Transfecting H19-7 and b.End3 cells with a serine-133 phosphorylation mutant CREB also inhibited VEGF-A's protection of both types of cells. We conclude that CREB phosphorylation through VEGFR-2/ERK signaling is the shared pathway that underlies VEGF-A's protection of neurons and vascular endothelial cells.",
keywords = "cAMP response element-binding protein, Endothelial cell, Hypoxia, Neuron, Vascular endothelial growth factor receptor-2, Vascular endothelial growth factor-A",
author = "Lee, {Hsueh Te} and Chang, {Ying Chao} and Tu, {Yi Fang} and Huang, {Chao Ching}",
year = "2010",
month = "4",
doi = "10.1111/j.1471-4159.2010.06584.x",
language = "English",
volume = "113",
pages = "79--91",
journal = "Journal of Neurochemistry",
issn = "0022-3042",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - CREB activation mediates VEGF-A's protection of neurons and cerebral vascular endothelial cells

AU - Lee, Hsueh Te

AU - Chang, Ying Chao

AU - Tu, Yi Fang

AU - Huang, Chao Ching

PY - 2010/4

Y1 - 2010/4

N2 - Hypoxic ischemia (HI) in neonates causes significant neurodevelopmental sequelae. Pharmacological agents designed to target specific transcription factors expressed in neurons and vasculature may provide powerful therapy against HI. Vascular endothelial growth factor-A (VEGF-A) and cAMP response element-binding protein (CREB) both underlie learning and memory, and survival of the nervous system. We examined whether CREB activation is a shared pathway underlying VEGF-A's protection in neurons and cerebral vascular endothelial cells. VEGF-A was used in a HI model of rat pups and in oxygen-glucose- deprivation (OGD) models of immortalized H19-7 neurons and b.End3 cerebral vascular endothelial cells. We found that VEGF-A activated VEGF receptor-2 (VEGFR-2), phosphorylated CREB in neurons and endothelial cells, and protected against HI, and inhibiting VEGFR-2 before VEGF-A reduced the protective effect of VEGF-A in rat pups. VEGF-A also up-regulated VEGFR-2 and phosphorylated CREB, and protected H19-7 neurons and b.End3 endothelial cells against OGD. Inhibiting VEGFR-2 and extracellular signal-regulated kinase (ERK), respectively, reduced VEGF-A-induced CREB phosphorylation and protection of H19-7 and b.End3 cells against OGD. Transfecting H19-7 and b.End3 cells with a serine-133 phosphorylation mutant CREB also inhibited VEGF-A's protection of both types of cells. We conclude that CREB phosphorylation through VEGFR-2/ERK signaling is the shared pathway that underlies VEGF-A's protection of neurons and vascular endothelial cells.

AB - Hypoxic ischemia (HI) in neonates causes significant neurodevelopmental sequelae. Pharmacological agents designed to target specific transcription factors expressed in neurons and vasculature may provide powerful therapy against HI. Vascular endothelial growth factor-A (VEGF-A) and cAMP response element-binding protein (CREB) both underlie learning and memory, and survival of the nervous system. We examined whether CREB activation is a shared pathway underlying VEGF-A's protection in neurons and cerebral vascular endothelial cells. VEGF-A was used in a HI model of rat pups and in oxygen-glucose- deprivation (OGD) models of immortalized H19-7 neurons and b.End3 cerebral vascular endothelial cells. We found that VEGF-A activated VEGF receptor-2 (VEGFR-2), phosphorylated CREB in neurons and endothelial cells, and protected against HI, and inhibiting VEGFR-2 before VEGF-A reduced the protective effect of VEGF-A in rat pups. VEGF-A also up-regulated VEGFR-2 and phosphorylated CREB, and protected H19-7 neurons and b.End3 endothelial cells against OGD. Inhibiting VEGFR-2 and extracellular signal-regulated kinase (ERK), respectively, reduced VEGF-A-induced CREB phosphorylation and protection of H19-7 and b.End3 cells against OGD. Transfecting H19-7 and b.End3 cells with a serine-133 phosphorylation mutant CREB also inhibited VEGF-A's protection of both types of cells. We conclude that CREB phosphorylation through VEGFR-2/ERK signaling is the shared pathway that underlies VEGF-A's protection of neurons and vascular endothelial cells.

KW - cAMP response element-binding protein

KW - Endothelial cell

KW - Hypoxia

KW - Neuron

KW - Vascular endothelial growth factor receptor-2

KW - Vascular endothelial growth factor-A

UR - http://www.scopus.com/inward/record.url?scp=77749264878&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77749264878&partnerID=8YFLogxK

U2 - 10.1111/j.1471-4159.2010.06584.x

DO - 10.1111/j.1471-4159.2010.06584.x

M3 - Article

VL - 113

SP - 79

EP - 91

JO - Journal of Neurochemistry

JF - Journal of Neurochemistry

SN - 0022-3042

IS - 1

ER -